Markus Renschler, Light House Therapeutics
CEO experienced in building companies, raising capital in private and public markets, and developing oncology drugs. Led Cyteir from start-up to public clinical stage company. Board certified medical oncologist with 25 years’ experience in cancer research from basic laboratory research to drug approval and commercialization. Experienced in recruiting and motivating teams. Successful global registrations in breast cancer, non-small cell lung cancer and pancreatic cancer.
